DIA
CYTK icon

Denver Investment Advisors’s Cytokinetics CYTK Stock Holding History

Denver Investment Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-10,203
Closed -$72K – 461
2016
Q1 		$72K Sell
10,203
-3,234
-24% -$23.6K ﹤0.01% 452
2015
Q4 		$141K Sell
13,437
-1,526
-10% -$15K 0.01% 464
2015
Q3 		$100K Sell
14,963
-515
-3% -$3.52K ﹤0.01% 505
2015
Q2 		$104K Buy
+15,478
New +$101K ﹤0.01% 543

Other funds holding CYTK

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Denver Investment Advisors's CYTK Position: Q2 2016 in Review

Denver Investment Advisors sold out of Cytokinetics (CYTK) in Q2 2016, closing a stake of 10,203 shares — an estimated $72K sold.

Denver Investment Advisors first reported a position in CYTK in Q2 2015 and held it in 4 quarters. The position peaked at $141K in Q4 2015. 95 funds tracked by Wall St. Rank hold CYTK as of Q2 2016.

  • Denver Investment Advisors reported no remaining Cytokinetics position as of Q2 2016 after selling out during the quarter.
  • Denver Investment Advisors sold 10,203 Cytokinetics shares in Q2 2016, an estimated $72K.
  • Denver Investment Advisors first reported a position in Cytokinetics in Q2 2015 and held it in 4 quarters.
  • Denver Investment Advisors's Cytokinetics position peaked at $141K in Q4 2015.
  • 95 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2016.

Based on Denver Investment Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.